La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Parkinson Disease (drug therapy) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Parkinson Disease (diet therapy) < Parkinson Disease (drug therapy) < Parkinson Disease (economics)  Facettes :

List of bibliographic references indexed by Parkinson Disease (drug therapy)

Number of relevant bibliographic references: 464.
[0-50] [0 - 20][0 - 50][50-70]
Ident.Authors (with country if any)Title
000153 (2016) Qing He [République populaire de Chine] ; James B. Koprich [Canada] ; Ying Wang [République populaire de Chine] ; Wen-Bo Yu [République populaire de Chine] ; Bao-Guo Xiao [République populaire de Chine] ; Jonathan M. Brotchie [Canada] ; Jian Wang [République populaire de Chine]Treatment with Trehalose Prevents Behavioral and Neurochemical Deficits Produced in an AAV α-Synuclein Rat Model of Parkinson's Disease.
000222 (2016) Mauro Pettorruso [Italie] ; Alfonso Fasano [Canada] ; Luisa De Risio [Italie] ; Lucia Ricciardi [Royaume-Uni] ; Marco Di Nicola [Italie] ; Giovanni Martinotti [Italie] ; Luigi Janiri [Italie] ; Anna Rita Bentivoglio [Italie]Punding in non-demented Parkinson's disease patients: Relationship with psychiatric and addiction spectrum comorbidity.
000224 (2016) Anna Chang [Canada] ; Susan H. Fox [Canada]Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.
000249 (2016) Fariborz Rahimi [Iran] ; Angela C. Roberts [États-Unis] ; Mandar Jog [Canada]Patterns and predictors of freezing of gait improvement following rasagiline therapy: A pilot study.
000265 (2016) Priti Gros [Canada] ; Victoria P. Mery [Chili] ; Anne-Louise Lafontaine [Canada] ; Ann Robinson [Canada] ; Andrea Benedetti [Canada] ; R John Kimoff [Canada] ; Marta Kaminska [Canada]Obstructive sleep apnea in Parkinson's disease patients: effect of Sinemet CR taken at bedtime.
000284 (2016) Enkhjargal Bayarsaikhan [Corée du Sud, Mongolie] ; Delger Bayarsaikhan [Corée du Sud] ; Jaesuk Lee [Corée du Sud] ; Myeongjoo Son [Corée du Sud] ; Seyeon Oh [Corée du Sud] ; Jeongsik Moon [Corée du Sud] ; Hye-Jeong Park [Corée du Sud] ; Arivazhagan Roshini [Corée du Sud] ; Seung U. Kim [Canada] ; Byoung-Joon Song [États-Unis] ; Seung-Mook Jo [Corée du Sud] ; Kyunghee Byun [Corée du Sud] ; Bonghee Lee [Corée du Sud]Microglial AGE-albumin is critical for neuronal death in Parkinson’s disease: a possible implication for theranostics
000302 (2016) Connie Marras [Canada] ; Nathan Herrmann [Canada] ; Hadas D. Fischer [Canada] ; Kinwah Fung [Canada] ; Andrea Gruneir [Canada] ; Paula A. Rochon [Canada] ; Soham Rej [Canada] ; Simone Vigod [Canada] ; Dallas Seitz [Canada] ; Kenneth I. Shulman [Canada]Lithium Use in Older Adults is Associated with Increased Prescribing of Parkinson Medications.
000314 (2016) F. Pieruccini-Faria [Canada] ; J A Jones [Canada] ; Q J Almeida [Canada]Insight into dopamine-dependent planning deficits in Parkinson's disease: A sharing of cognitive & sensory resources.
000333 (2016) Cicely Kerr [Royaume-Uni] ; Emily J. Lloyd [Royaume-Uni] ; Charlotte E. Kosmas [Royaume-Uni] ; Helen T. Smith [Royaume-Uni] ; James A. Cooper [Royaume-Uni] ; Karissa Johnston [Canada] ; Emma Mcintosh [Royaume-Uni] ; Andrew J. Lloyd [Royaume-Uni]Health-related quality of life in Parkinson's: impact of 'off' time and stated treatment preferences.
000364 (2016) Yan Xu [République populaire de Chine] ; Yanyan Zhang [République populaire de Chine] ; Zhenzhen Quan [République populaire de Chine] ; Winnie Wong [Canada] ; Jianping Guo [Canada] ; Rongkai Zhang [République populaire de Chine] ; Qinghu Yang [République populaire de Chine] ; Rongji Dai [République populaire de Chine] ; Patrick L. Mcgeer [Canada] ; Hong Qing [République populaire de Chine]Epigallocatechin Gallate (EGCG) Inhibits Alpha-Synuclein Aggregation: A Potential Agent for Parkinson's Disease.
000375 (2016) Leslie Wayne Ferguson [Canada] ; Ali H. Rajput [Canada] ; Alexander Rajput [Canada]Early-onset vs. Late-onset Parkinson's disease: A Clinical-pathological Study.
000398 (2016) Doris E. Payer ; Mark Guttman ; Stephen J. Kish ; Junchao Tong ; John R. Adams ; Pablo Rusjan ; Sylvain Houle ; Yoshiaki Furukawa ; Alan A. Wilson ; Isabelle BoileauD3 dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesia
000413 (2016) John L. Goudreau [États-Unis] ; Adriana Pérez [États-Unis] ; Michael J. Aminoff [États-Unis] ; James T. Boyd [États-Unis] ; Keith D. Burau [États-Unis] ; Chadwick W. Christine [États-Unis] ; Maureen Leehey [États-Unis] ; John C. Morgan [États-Unis]Choice of dopaminergic therapy among early, mild Parkinson disease subjects in North America.
000424 (2016) Marc Morissette [Canada] ; Nicolas Morin [Canada] ; Laurent Grégoire [Canada] ; Alex Rajput [Canada] ; Ali H. Rajput [Canada] ; Thérèse Di Paolo [Canada]Brain α7 nicotinic acetylcholine receptors in MPTP-lesioned monkeys and parkinsonian patients.
000427 (2016) Veronica A. Bruno [Canada] ; Susan H. Fox [Canada] ; Deborah Mancini [Canada] ; Janis M. Miyasaki [Canada]Botulinum Toxin Use in Refractory Pain and Other Symptoms in Parkinsonism.
000450 (2016) Maribel Márquez-Cruz [Mexique] ; Juan Pablo Díaz-Martínez [Canada] ; Herman Soto-Molina [Mexique] ; Adib Jorge De Saráchaga [Mexique] ; Amin Cervantes-Arriaga [Mexique] ; Rodrigo Llorens-Arenas [Mexique] ; Mayela Rodríguez-Violante [Mexique]A systematic review and mixed treatment comparison of monotherapy in early Parkinson's disease: implications for Latin America.
000457 (2016) Marcello Moccia [Italie] ; Roberto Erro [Royaume-Uni, Italie] ; Marina Picillo [Italie, Canada] ; Gabriella Santangelo [Italie] ; Emanuele Spina [Italie] ; Roberto Allocca [Italie] ; Katia Longo [Italie] ; Marianna Amboni [Italie] ; Raffaele Palladino [Royaume-Uni, Italie] ; Roberta Assante [Italie] ; Sabina Pappatà [Italie] ; Maria Teresa Pellecchia [Italie] ; Paolo Barone [Italie] ; Carmine Vitale [Italie]A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease
000459 (2016) Jennifer Liebenthal [États-Unis] ; Jason Valerio [Canada] ; Chad Ruoff [États-Unis] ; Mark Mahowald [États-Unis]A Case of Rapid Eye Movement Sleep Behavior Disorder in Parkinson Disease Treated With Sodium Oxybate.
000464 (2016) Lucia Ricciardi [Royaume-Uni] ; Francesco Bove [Italie] ; Kristy J. Espay [États-Unis] ; Francesco Lena [Italie] ; Nicola Modugno [Italie] ; Yu-Yan Poon [Canada] ; Robert Krikorian [États-Unis] ; Alberto J. Espay [États-Unis] ; Alfonso Fasano [Canada]24-Hour infusion of levodopa/carbidopa intestinal gel for nocturnal akinesia in advanced Parkinson's disease.
000474 (2015) Tiago A. Mestre [Canada] ; Isabelle Beaulieu-Boire [Canada] ; Camila C. Aquino [Canada] ; Nicolas Phielipp [États-Unis] ; Yu Yan Poon [Canada] ; Jane P. Lui [Canada] ; Julie So [Canada] ; Susan H. Fox [Canada]What is a clinically important change in the Unified Dyskinesia Rating Scale in Parkinson's disease?
000476 (2015) Kaylena A. Ehgoetz Martens [Canada] ; Colin G. Ellard [Canada] ; Quincy J. Almeida [Canada]Virtually-induced threat in Parkinson's: Dopaminergic interactions between anxiety and sensory-perceptual processing while walking.
000483 (2015) James A. G. Crispo [États-Unis] ; Yannick Fortin ; Dylan P. Thibault [États-Unis] ; Matthew Emons [États-Unis] ; Lise M. Bjerre ; Dafna E. Kohen ; Santiago Perez-Lloret [Argentine] ; Donald Mattison ; Allison W. Willis [États-Unis] ; Daniel KrewskiTrends in inpatient antiparkinson drug use in the USA, 2001–2012
000488 (2015) Janelle Drouin-Ouellet ; Isabelle St-Amour ; Martine Saint-Pierre ; Jérôme Lamontagne-Proulx ; Jasna Kriz ; Roger A. Barker ; Francesca CicchettiToll-Like Receptor Expression in the Blood and Brain of Patients and a Mouse Model of Parkinson’s Disease
000505 (2015) Matt J N. Brown [Canada] ; Quincy J. Almeida ; Fariborz RahimiThe dopaminergic system in upper limb motor blocks (ULMB) investigated during bimanual coordination in Parkinson's disease (PD).
000524 (2015) Paolo Solla [Italie] ; Alfonso Fasano [Canada] ; Antonino Cannas [Italie] ; Francesco Marrosu [Italie]Suicide and dopamine agonist withdrawal syndrome in Parkinson's disease.
000527 (2015) Fariborz Rahimi [Canada] ; Carina Bee [Irlande (pays)] ; David Wang [Canada] ; Farrokh Janabi-Sharifi [Canada] ; Quincy J. Almeida [Canada]Subgroup analysis of PD tremor with loading: action tremor as a combination of classical rest and physiological tremor.
000538 (2015) Emma D. Deeks [Oman]Safinamide: first global approval.
000542 (2015) Tanja Tran [Canada] ; James M. Brophy [Canada] ; Samy Suissa [Canada] ; Christel Renoux [Canada]Risks of Cardiac Valve Regurgitation and Heart Failure Associated with Ergot- and Non-Ergot-Derived Dopamine Agonist Use in Patients with Parkinson's Disease: A Systematic Review of Observational Studies.
000568 (2015) Constant V. M. Verschuur [Pays-Bas] ; S. R. Suwijn [Pays-Bas] ; B. Post [Pays-Bas] ; M. Dijkgraaf [Pays-Bas] ; B. R. Bloem [Pays-Bas] ; J. J. Van Hilten [Pays-Bas] ; T. Van Laar [Pays-Bas] ; G. Tissingh [Pays-Bas] ; G. Deuschl [Allemagne] ; A. E. Lang [Canada] ; R. J. De Haan [Pays-Bas] ; R. M. A. De Bie [Pays-Bas]Protocol of a randomised delayed-start double-blind placebo-controlled multi-centre trial for Levodopa in EArly Parkinson’s disease: the LEAP-study
000581 (2015) Alberto J. Espay ; Matthew M. Norris ; James C. Eliassen ; Alok Dwivedi ; Matthew S. Smith ; Christi Banks ; Jane B. Allendorfer ; Anthony E. Lang ; David E. Fleck ; Michael J. Linke ; Jerzy P. SzaflarskiPlacebo effect of medication cost in Parkinson disease
000592 (2015) Matthieu F. Bastide [France] ; Wassilios G. Meissner [France] ; Barbara Picconi [Italie] ; Stefania Fasano [Italie] ; Pierre-Olivier Fernagut [France] ; Michael Feyder [Suède] ; Veronica Francardo [Suède] ; Cristina Alcacer [Suède] ; Yunmin Ding [États-Unis] ; Riccardo Brambilla [Italie] ; Gilberto Fisone [Suède] ; A. Jon Stoessl [Canada] ; Mathieu Bourdenx [France] ; Michel Engeln [France] ; Sylvia Navailles [France] ; Philippe De Deurwaerdère [France] ; Wai Kin D. Ko [France] ; Nicola Simola [Italie] ; Micaela Morelli [Italie] ; Laurent Groc [France] ; Maria-Cruz Rodriguez [Espagne] ; Eugenia V. Gurevich [États-Unis] ; Maryka Quik [États-Unis] ; Michele Morari [Italie] ; Manuela Mellone [Italie] ; Fabrizio Gardoni [Italie] ; Elisabetta Tronci [Italie] ; Dominique Guehl [France] ; François Tison [France] ; Alan R. Crossman [Royaume-Uni] ; Un Jung Kang [Suède] ; Kathy Steece-Collier [États-Unis] ; Susan Fox [Canada] ; Manolo Carta [Italie] ; M. Angela Cenci [Suède] ; Erwan Bézard [Royaume-Uni]Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease.
000597 (2015) Brian J. Lithgow [Canada] ; Mehrnaz Shoushtarian [Oman]Parkinson's disease: disturbed vestibular function and levodopa.
000601 (2015) Philip Seeman [Canada]Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors.
000618 (2015) Simon YoungObituary of Theodore L. Sourkes, PhD, FRSC, OC
000642 (2015) I. Aracil-Bola Os [Canada] ; A. P. Strafella [Canada]Molecular imaging and neural networks in impulse control disorders in Parkinson’s disease
000674 (2015) Anthony E. Lang ; Ramon L. Rodriguez ; James T. Boyd ; Sylvain Chouinard ; Cindy Zadikoff ; Alberto J. Espay ; John T. Slevin ; Hubert H. Fernandez ; Mark F. Lew ; David A. Stein ; Per Odin ; Victor S. C. Fung ; Fabian Klostermann ; Alfonso Fasano ; Peter V. Draganov ; Nathan Schmulewitz ; Weining Z. Robieson ; Susan Eaton ; Krai Chatamra ; Janet A. Benesh ; Jordan DubowIntegrated safety of levodopa‐carbidopa intestinal gel from prospective clinical trials
000676 (2015) Alfonso Fasano [Canada] ; Louis W C. Liu ; Yu-Yan Poon ; Antony E. LangInitiating intrajejunal infusion of levodopa/carbidopa intestinal gel: an outpatient model.
000683 (2015) Pierre J. Blanchet [Canada] ; Emmanuelle PourcherIn memoriam: Paul J. Bédard, MD PhD: January 19, 1942-December 26, 2014.
000687 (2015) David Mongeon [Canada] ; Pierre Blanchet ; Stéphanie Bergeron ; Julie MessierImpact of Parkinson's disease on proprioceptively based on-line movement control.
000689 (2015) Clive Ballard [Royaume-Uni] ; Stuart Isaacson [États-Unis] ; Roger Mills [États-Unis] ; Hilde Williams [États-Unis] ; Anne Corbett [Royaume-Uni] ; Bruce Coate [États-Unis] ; Rajesh Pahwa [États-Unis] ; Olivier Rascol [France] ; David J. Burn [Royaume-Uni]Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People With Parkinson Disease Psychosis.
000718 (2015) Alfonso Fasano [Canada] ; Naomi P. Visanji [Canada] ; Louis W C. Liu [Canada] ; Antony E. Lang [Canada] ; Ronald F. Pfeiffer [États-Unis]Gastrointestinal dysfunction in Parkinson's disease.
000731 (2015) Zaijun Zhang [République populaire de Chine] ; Guohui Li [République populaire de Chine] ; Samuel S W. Szeto [République populaire de Chine] ; Cheong Meng Chong [République populaire de Chine] ; Quan Quan [République populaire de Chine] ; Chen Huang [République populaire de Chine] ; Wei Cui [République populaire de Chine] ; Baojian Guo [République populaire de Chine] ; Yuqiang Wang [République populaire de Chine] ; Yifan Han [République populaire de Chine] ; K W Michael Siu [Canada] ; Simon Ming Yuen Lee [République populaire de Chine] ; Ivan K. Chu [République populaire de Chine]Examining the neuroprotective effects of protocatechuic acid and chrysin on in vitro and in vivo models of Parkinson disease.
000735 (2015) Justine Renaud [Canada] ; Seyed Fazel Nabavi [Iran] ; Maria Daglia [Italie] ; Seyed Mohammad Nabavi [Iran] ; Maria-Grazia Martinoli [Canada]Epigallocatechin-3-Gallate, a Promising Molecule for Parkinson's Disease?
000747 (2015) Karl Kieburtz [États-Unis] ; Barbara C. Tilley ; Jordan J. Elm ; Debra Babcock [États-Unis] ; Robert Hauser [États-Unis] ; G Webster Ross [États-Unis] ; Alicia H. Augustine [États-Unis] ; Erika U. Augustine [États-Unis] ; Michael J. Aminoff [États-Unis] ; Ivan G. Bodis-Wollner ; James Boyd ; Franca Cambi ; Kelvin Chou ; Chadwick W. Christine [États-Unis] ; Michelle Cines [États-Unis] ; Nabila Dahodwala [États-Unis] ; Lorelei Derwent [Canada] ; Richard B. Dewey ; Katherine Hawthorne [États-Unis] ; David J. Houghton [États-Unis] ; Cornelia Kamp [États-Unis] ; Maureen Leehey ; Mark F. Lew [États-Unis] ; Grace S Lin Liang [États-Unis] ; Sheng T. Luo ; Zoltan Mari [États-Unis] ; John C. Morgan ; Sotirios Parashos [États-Unis] ; Adriana Pérez ; Helen Petrovitch [États-Unis] ; Suja Rajan ; Sue Reichwein [États-Unis] ; Jessie Tatsuno Roth [États-Unis] ; Jay S. Schneider [États-Unis] ; Kathleen M. Shannon [États-Unis] ; David K. Simon [États-Unis] ; Tanya Simuni [États-Unis] ; Carlos Singer [États-Unis] ; Lewis Sudarsky [États-Unis] ; Caroline M. Tanner [États-Unis] ; Chizoba C. Umeh [États-Unis] ; Karen Williams [États-Unis] ; Anne-Marie Wills [États-Unis]Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial.
000748 (2015) Mariano Serrao [Italie] ; Alberto Ranavolo [Italie] ; Carmela Conte [Italie] ; Chiara Davassi [Italie] ; Silvia Mari [Italie] ; Alfonso Fasano [Canada] ; Giorgia Chini [Italie] ; Gianluca Coppola [Italie] ; Francesco Draicchio [Italie] ; Francesco Pierelli [Italie]Effect of 24-h continuous rotigotine treatment on stationary and non-stationary locomotion in de novo patients with Parkinson disease in an open-label uncontrolled study.
000750 (2015) Joe Kakish ; Dongsoo Lee ; Jeremy S. LeeDrugs That Bind to α-Synuclein: Neuroprotective or Neurotoxic?
000752 (2015) Paolo Solla [Italie] ; Alfonso Fasano [Canada] ; Antonino Cannas [Italie] ; Cesare Salvatore Mulas [Italie] ; Maria Giovanna Marrosu [Italie] ; Anthony E. Lang [Canada] ; Francesco Marrosu [Italie]Dopamine agonist withdrawal syndrome (DAWS) symptoms in Parkinson's disease patients treated with levodopa-carbidopa intestinal gel infusion.
000769 (2015) Mateusz Zurowski [Canada] ; Jonathan Darcy O'BrienDevelopments in impulse control behaviours of Parkinson's disease.
000771 (2015) Line Beaudet [Canada] ; Francine Ducharme [Canada] ; Nathalie L'Écuyer [Canada] ; Sylvain Chouinard [Canada] ; Nicolas Jodoin [Canada] ; Michel Panisset [Canada]Development and evaluation of a dyadic intervention for elderly couples living with moderate-stage Parkinson disease.
000786 (2015) Nicolas Morin [Canada] ; Marc Morissette [Canada] ; Laurent Grégoire [Canada] ; Alex Rajput [Canada] ; Ali H. Rajput [Canada] ; Thérèse Di Paolo [Canada]Contribution of brain serotonin subtype 1B receptors in levodopa-induced motor complications.
000788 (2015) Alison C. Simioni ; Alain Dagher ; Lesley K. FellowsCompensatory striatal–cerebellar connectivity in mild–moderate Parkinson's disease

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Parkinson Disease (drug therapy)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Parkinson Disease (drug therapy)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Parkinson Disease (drug therapy)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022